Stevanato Group

Update in progress

STVN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Stevanato Group S.p.A. designs, produces, and distributes solutions for biopharma and healthcare across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Operating in two segments—Biopharmaceutical and Diagnostic Solutions; and Engineering—it offers drug containment products (syringes, vials, cartridges, ampoules), delivery devices, diagnostic kits, lab consumables, and equipment for packaging and inspection. It also provides contract development and manufacturing for customer devices. Founded 1949, based in Piombino Dese, Italy; a Stevanato Holding S.R.L. subsidiary.

Company score

Sentiment: 0.43; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.26; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.29; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.03; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.18; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.30; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive